Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach

Starting soon

Conditions studied: Acute Kidney Disease

In brief

Renal injury after cardiac surgery is one of the common complications with high incidence rate, high risk of death and progression to chronic kidney disease (CKD). Previous evaluations of perioperative renal function mainly focused on acute kidney injury (AKI) related to cardiac surgery within seven days after surgery. The newly proposed concept of acute kidney disease (AKD) in recent years refers to acute or subacute kidney injury lasting seven to ninety days. Research has found that AKD can occur after AKI or in patients without AKI, and the two are both related and independent of each other, possibly indicating different subtypes of kidney injury. AKD is not uncommon and is a more significant predictor of mortality and end-stage kidney disease (ESKD). Therefore, AKD may be an important window for identifying and managing high-risk patients after cardiac surgery. Due to limited research on AKD after cardiac surgery, the risk factors for AKD are currently unclear, and there are no clinically practical and effective risk stratification tools available. This study aims to establish a multimodal perioperative data platform through a retrospective cohort, and use machine learning methods to construct a risk prediction model for AKD after cardiac surgery. The accuracy and stability of the model will be validated in a prospective study cohort, and an online risk prediction and clinical decision-making tool will be developed to help clinicians quickly conduct personalized risk assessments and optimize diagnosis and treatment strategies, thereby improving patient prognosis and reducing medical costs.

Key facts

Study ID

NCT07482683

Run by

China National Center for Cardiovascular Diseases

People needed

820

Starts

2026-03-01

Expected to finish

2027-06-30

Last updated by the study team

2026-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years;
• Undergoing coronary artery bypass grafting and/or heart valve surgery, with or without aortic surgery;
• Baseline serum creatinine level < 354 umol/L;
• Informed consent obtained.

You may not qualify if…

• Emergency surgery;
• Multiple surgeries or reoperation;
• End-stage kidney disease (ESKD), renal replacement therapy, or kidney transplantation;
• Occurrence of AKI within 1 week before surgery or unresolved AKI;
• Death within 1 week after surgery.

Where it is running

• National Center for Cardiovascular Diseases — Beijing, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.